| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Medivie Therapeutic Ltd (TA: MDVI)
MDVI Technical Analysis
3
| As on 19th Nov 2025 MDVI STOCK Price closed @ 80.20 and we RECOMMEND Buy for LONG-TERM with Stoploss of 53.68 & Buy for SHORT-TERM with Stoploss of 78.66 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MDVISTOCK Price
| Open | 82.50 | Change | Price | % |
| High | 82.50 | 1 Day | -4.90 | -5.76 |
| Low | 80.10 | 1 Week | -7.50 | -8.55 |
| Close | 80.20 | 1 Month | -6.70 | -7.71 |
| Volume | 5651 | 1 Year | -30.10 | -27.29 |
| 52 Week High 128.00 | 52 Week Low 17.00 | ||||
TA Israel Most Active Stocks
| TA125 | 2008.05 | 1.06% |
| BEZQ | 647.00 | 2.07% |
| BLRX | 1.70 | -5.56% |
| ORL | 107.60 | 4.77% |
| KTOV | 1.20 | 9.09% |
| GNRS | 121.80 | 0.00% |
| DSCT | 3432.00 | 0.23% |
| GODM | 68.00 | 22.97% |
| LUMI | 6980.00 | 2.62% |
| ICL | 1788.00 | 1.59% |
TA Israel Top Gainers Stocks
TA Israel Top Losers Stocks
| MDVI Daily Charts |
MDVI Intraday Charts |
Whats New @ Bazaartrend |
MDVI Free Analysis |
|
|
MDVI Important Levels Intraday
| RESISTANCE | 84.82 |
| RESISTANCE | 83.34 |
| RESISTANCE | 82.42 |
| RESISTANCE | 81.51 |
| SUPPORT | 78.89 |
| SUPPORT | 77.98 |
| SUPPORT | 77.06 |
| SUPPORT | 75.58 |
MDVI Forecast November 2025
| 4th UP Forecast | 121.25 |
| 3rd UP Forecast | 108.08 |
| 2nd UP Forecast | 99.95 |
| 1st UP Forecast | 91.81 |
| 1st DOWN Forecast | 68.59 |
| 2nd DOWN Forecast | 60.45 |
| 3rd DOWN Forecast | 52.32 |
| 4th DOWN Forecast | 39.15 |
MDVI Weekly Forecast
| 4th UP Forecast | 123.56 |
| 3rd UP Forecast | 109.65 |
| 2nd UP Forecast | 101.06 |
| 1st UP Forecast | 92.46 |
| 1st DOWN Forecast | 67.94 |
| 2nd DOWN Forecast | 59.34 |
| 3rd DOWN Forecast | 50.75 |
| 4th DOWN Forecast | 36.84 |
MDVI Forecast2025
| 4th UP Forecast | 298.34 |
| 3rd UP Forecast | 228.38 |
| 2nd UP Forecast | 185.14 |
| 1st UP Forecast | 141.89 |
| 1st DOWN Forecast | 18.51 |
| 2nd DOWN Forecast | -24.74 |
| 3rd DOWN Forecast | -67.98 |
| 4th DOWN Forecast | -137.94 |
Medivie Therapeutic Ltd ( TA Israel Symbol : MDVI )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MDVI Business Profile
Medivie Therapeutic Limited develops and markets dental devices. It offers Laboraide, a dental device that is placed between the woman's lower and upper jaw during birth, which allows the relaxation of the jaw, neck, and head muscles through the flow of oxygen to the muscles. The company also develops modular pacifiers that enables development of mouth structure and prevent future damage to the child's gingival structure and teeth. Its product has applications in the areas of birth, migraines, chronic pains, and improving concentration and cognitive activity. The company markets and distributes its products through a network of distributors, as well as online in the Asia, Latin America, the United States, Europe, and Canada. Medivie Therapeutic Limited was founded in 2012 and is based in Hemel Hempstead, the United Kingdom. Address: 1 The Willows, Hemel Hempstead, United Kingdom, HP2 7BN
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service